Literature DB >> 23945160

Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.

T Cerar1, K Ogrinc, S Lotric-Furlan, J Kobal, S Levicnik-Stezinar, F Strle, E Ruzić-Sabljic.   

Abstract

The aims of the present study were to assess the concentrations of different cytokines and chemokines in blood serum and cerebrospinal fluid (CSF) samples of patients with Lyme neuroborreliosis and to identify the possible marker(s) that would enable a distinction between clinically evident and suspected Lyme neuroborreliosis, as well as between Lyme neuroborreliosis and tick-borne encephalitis (TBE). Our additional interest was to evaluate the relationship between cytokine and chemokine concentrations and Borrelia burgdorferi sensu lato isolation from CSF, as well as intrathecal synthesis of specific borrelial antibodies. We found that higher concentrations of CXCL13 and lower concentrations of interleukin 10 (IL-10) in serum were associated with higher odds for clinically evident Lyme neuroborreliosis compared to suspected Lyme neuroborreliosis, as well as to TBE. The concentrations of IL-2, IL-5, IL-6, IL-10, and CXCL13 in the CSF were higher in patients with evident Lyme neuroborreliosis than in those who were only suspected to have the disease. A comparison of CSF cytokine and chemokine levels in patients with and without intrathecal synthesis of specific borrelial antibodies revealed that CXCL13 CSF concentration is significantly associated with intrathecal synthesis of borrelial antibodies. A comparison of the cytokine and chemokine CSF concentrations in patients with clinically evident Lyme neuroborreliosis according to CSF culture results revealed that higher concentrations of gamma interferon (IFN-γ) were associated with lower odds of Borrelia isolation. Although several differences in the blood serum and CSF concentrations of various cytokines and chemokines between the groups were found, the distinctive power of the majority of these findings is low. Further research on well-defined groups of patients is needed to appraise the potential diagnostic usefulness of these concentrations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23945160      PMCID: PMC3807194          DOI: 10.1128/CVI.00353-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  33 in total

1.  The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis.

Authors:  Sabine Cepok; Dun Zhou; Friederike Vogel; Berit Rosche; Verena Grummel; Norbert Sommer; Bernhard Hemmer
Journal:  Arch Neurol       Date:  2003-06

2.  Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia.

Authors:  Eva Ruzić-Sabljić; Vera Maraspin; Stanka Lotric-Furlan; Tomaz Jurca; Mateja Logar; Andreja Pikelj-Pecnik; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2002-07-31       Impact factor: 1.704

3.  Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis.

Authors:  M Grusell; M Widhe; C Ekerfelt
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

4.  Activation-dependent modulation of B lymphocyte migration to chemokines.

Authors:  M Brandes; D F Legler; B Spoerri; P Schaerli; B Moser
Journal:  Int Immunol       Date:  2000-09       Impact factor: 4.823

Review 5.  Lyme borreliosis.

Authors:  Gerold Stanek; Franc Strle
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

6.  Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.

Authors:  S Hammers-Berggren; K Hansen; A M Lebech; M Karlsson
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

7.  Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto.

Authors:  R Kaiser; S Rauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

8.  Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.

Authors:  A Keane-Myers; S P Nickell
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

9.  Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.

Authors:  A P van Dam; H Kuiper; K Vos; A Widjojokusumo; B M de Jongh; L Spanjaard; A C Ramselaar; M D Kramer; J Dankert
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

10.  Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.

Authors:  Daniel Bremell; Niklas Mattsson; Mikael Edsbagge; Kaj Blennow; Ulf Andreasson; Carsten Wikkelsö; Henrik Zetterberg; Lars Hagberg
Journal:  BMC Neurol       Date:  2013-01-07       Impact factor: 2.474

View more
  20 in total

1.  [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].

Authors:  T A Rupprecht; C Lechner; H Tumani; V Fingerle
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

Review 2.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  [CXCL-13 as a biomarker in the diagnostics of neuroborreliosis].

Authors:  C Waiß; W Kindler; B Ströbele; C Aspöck; S Oberndorfer
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

4.  Laboratory testing for lyme neuroborreliosis--reply.

Authors:  Michael T Melia; Paul M Lantos; Paul G Auwaerter
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

Review 5.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

6.  Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis.

Authors:  Jörg Steinmann; Jürgen Held; Katharina Ziegler; Anca Rath; Christoph Schoerner; Renate Meyer; Thomas Bertsch; Frank Erbguth; Christian Bogdan
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

7.  Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12.

Authors:  Frederik R van de Schoor; Hedwig D Vrijmoeth; Michelle A E Brouwer; Hadewych J M Ter Hofstede; Heidi L M Lemmers; Helga Dijkstra; Collins K Boahen; Marije Oosting; Bart-Jan Kullberg; Joppe W Hovius; Cees C van den Wijngaard; Frank L van de Veerdonk; Mihai G Netea; Leo A B Joosten
Journal:  Infect Immun       Date:  2022-02-07       Impact factor: 3.609

8.  Laboratory diagnostics for Lyme disease.

Authors:  L R Lindsay; K Bernat; A Dibernardo
Journal:  Can Commun Dis Rep       Date:  2014-05-29

Review 9.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

10.  The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.

Authors:  R Dersch; T Hottenrott; M Senel; V Lehmensiek; H Tumani; S Rauer; O Stich
Journal:  Fluids Barriers CNS       Date:  2015-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.